List of Tables
Table 1. Cannabinoid-based Antitumor Drug Market Trends
Table 2. Cannabinoid-based Antitumor Drug Market Drivers & Opportunity
Table 3. Cannabinoid-based Antitumor Drug Market Challenges
Table 4. Cannabinoid-based Antitumor Drug Market Restraints
Table 5. Global Cannabinoid-based Antitumor Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cannabinoid-based Antitumor Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cannabinoid-based Antitumor Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Cannabinoid-based Antitumor Drug
Table 10. Global Cannabinoid-based Antitumor Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cannabinoid-based Antitumor Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cannabinoid-based Antitumor Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cannabinoid-based Antitumor Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cannabinoid-based Antitumor Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cannabinoid-based Antitumor Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cannabinoid-based Antitumor Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cannabinoid-based Antitumor Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cannabinoid-based Antitumor Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cannabinoid-based Antitumor Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cannabinoid-based Antitumor Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cannabinoid-based Antitumor Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cannabinoid-based Antitumor Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cannabinoid-based Antitumor Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cannabinoid-based Antitumor Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Cannabinoid-based Antitumor Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cannabinoid-based Antitumor Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cannabinoid-based Antitumor Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cannabinoid-based Antitumor Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Cannabics Inc. Basic Information List
Table 32. Cannabics Inc. Description and Business Overview
Table 33. Cannabics Inc. Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Cannabics Inc. (2019-2024)
Table 35. Cannabics Inc. Recent Developments
Table 36. Tikun Olam Basic Information List
Table 37. Tikun Olam Description and Business Overview
Table 38. Tikun Olam Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Tikun Olam (2019-2024)
Table 40. Tikun Olam Recent Developments
Table 41. Jay Pharma Basic Information List
Table 42. Jay Pharma Description and Business Overview
Table 43. Jay Pharma Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Jay Pharma (2019-2024)
Table 45. Jay Pharma Recent Developments
Table 46. GW Pharmaceuticals Basic Information List
Table 47. GW Pharmaceuticals Description and Business Overview
Table 48. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of GW Pharmaceuticals (2019-2024)
Table 50. GW Pharmaceuticals Recent Developments
Table 51. Medicanja Ltd Basic Information List
Table 52. Medicanja Ltd Description and Business Overview
Table 53. Medicanja Ltd Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Medicanja Ltd (2019-2024)
Table 55. Medicanja Ltd Recent Developments
Table 56. Valeant Pharmaceuticals Basic Information List
Table 57. Valeant Pharmaceuticals Description and Business Overview
Table 58. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Valeant Pharmaceuticals (2019-2024)
Table 60. Valeant Pharmaceuticals Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. Cannabinoid-based Antitumor Drug Downstream Customers
Table 64. Cannabinoid-based Antitumor Drug Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cannabinoid-based Antitumor Drug Product Picture
Figure 2. Global Cannabinoid-based Antitumor Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Cannabinoid-based Antitumor Drug Report Years Considered
Figure 5. Global Cannabinoid-based Antitumor Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabinoid-based Antitumor Drug Revenue in 2023
Figure 7. Cannabinoid-based Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Chewing Medicine Picture
Figure 9. Lozenge Picture
Figure 10. Other Picture
Figure 11. Global Cannabinoid-based Antitumor Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Cannabinoid-based Antitumor Drug Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Others
Figure 16. Global Cannabinoid-based Antitumor Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cannabinoid-based Antitumor Drug Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Cannabinoid-based Antitumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Cannabinoid-based Antitumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Cannabinoid-based Antitumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Cannabinoid-based Antitumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Cannabinoid-based Antitumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Cannabinoid-based Antitumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Cannabinoid-based Antitumor Drug Sales Value (%), (2019-2030)
Figure 29. United States Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. China Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. China Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. India Cannabinoid-based Antitumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Cannabinoid-based Antitumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. India Cannabinoid-based Antitumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. Cannabinoid-based Antitumor Drug Industrial Chain
Figure 51. Cannabinoid-based Antitumor Drug Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
